{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:15Z","timestamp":1791475455482,"version":"4.3.4"},"reference-count":110,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T00:00:00Z","timestamp":1180051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p><jats:bold>SUMMARY:\u2003<\/jats:bold> Approximately 5\u201310% of patients with chronic kidney disease demonstrate hyporesponsiveness to erythropoiesis\u2010stimulating agents (ESA), defined as a continued need for greater than 300\u2003IU\/kg per week erythropoietin or 1.5\u2003\u03bcg\/kg per week darbepoetin administered by the subcutaneous route. Such hyporesponsiveness contributes significantly to morbidity, mortality and health\u2010care economic burden in chronic kidney disease and represents an important diagnostic and management challenge. The commonest causes of ESA resistance are non\u2010compliance, absolute or functional iron deficiency and inflammation. It is widely accepted that maintaining adequate iron stores, ideally by administering iron parenterally, is the most important strategy for reducing the requirements for, and enhancing the efficacy of ESA. There have been recent epidemiologic studies linking parenteral iron therapy to an increased risk of infection and atherosclerosis, although other investigations have refuted this. Inflammatory ESA hyporesponsiveness has been reported to be improved by a number of interventions, including the use of biocompatible membranes, ultrapure dialysate, transplant nephrectomy, ascorbic acid therapy, vitamin E supplementation, statins and oxpentifylline administration. Other variably well\u2010established causes of ESA hyporesponsiveness include inadequate dialysis, hyperparathyroidism, nutrient deficiencies (vitamin B12, folate, vitamin C, carnitine), angiotensin\u2010converting enzyme inhibitors, angiotensin receptor blockers, aluminium overload, antibody\u2010mediated pure red cell aplasia, primary bone marrow disorders, myelosuppressive agents, haemoglobinopathies, haemolysis and hypersplenism. This paper reviews the causes of ESA hyporesponsiveness and the clinical evidence for proposed therapeutic interventions. A practical algorithm for approaching the investigation and management of patients with ESA hyporesponsiveness is also provided.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2007.00810.x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:10:32Z","timestamp":1180095032000},"page":"321-330","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Erythropoiesis\u2010stimulating agent hyporesponsiveness (Review Article)"],"prefix":"10.1111","volume":"12","author":[{"given":"DAVID W","family":"JOHNSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CAROL A","family":"POLLOCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IAIN C","family":"MACDOUGALL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,25]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"crossref","unstructured":"ValderrabanoF.Erythropoietin in chronic renal failure.Kidney Int.1996;50:1373\u201391.","DOI":"10.1038\/ki.1996.452"},{"key":"e_1_2_15_3_2","doi-asserted-by":"crossref","unstructured":"BenzRL PressmanMR HovickET PetersonDD.A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep sleep disorders and daytime sleepiness in hemodialysis patients (The SLEEPO study).Am. J. Kidney Dis.1999;34:1089\u201395.","DOI":"10.1016\/S0272-6386(99)70015-6"},{"key":"e_1_2_15_4_2","doi-asserted-by":"crossref","unstructured":"MacdougallIC CooperA.The inflammatory response and epoetin sensitivity.Nephrol. Dial. Transplant.2002;17(Suppl 1):48\u201352.","DOI":"10.1093\/ndt\/17.suppl_1.48"},{"key":"e_1_2_15_5_2","doi-asserted-by":"crossref","unstructured":"LocatelliF AljamaP BaranyPet\u2003al.Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.Nephrol. Dial. Transplant.2004;19(Suppl 2):ii1\u201347.","DOI":"10.1093\/ndt\/gfh1031"},{"key":"e_1_2_15_6_2","doi-asserted-by":"crossref","unstructured":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease.Am. J. Kidney Dis.2006;47:S11\u201345.","DOI":"10.1053\/j.ajkd.2006.03.011"},{"key":"e_1_2_15_7_2","doi-asserted-by":"crossref","unstructured":"JacobsC FreiD PerkinsAC.Results of the European Survey on Anaemia Management 2003 (ESAM 2003): Current status of anaemia management in dialysis patients factors affecting epoetin dosage and changes in anaemia management over the last 5\u2003years.Nephrol. Dial. Transplant.2005;20(Suppl 3):iii3\u201324.","DOI":"10.1093\/ndt\/gfh1074"},{"key":"e_1_2_15_8_2","doi-asserted-by":"crossref","unstructured":"MacdougallIC TuckerB ThompsonJ TomsonCR BakerLR RaineAE.A randomized controlled study of iron supplementation in patients treated with erythropoietin.Kidney Int.1996;50:1694\u20139.","DOI":"10.1038\/ki.1996.487"},{"key":"e_1_2_15_9_2","doi-asserted-by":"crossref","unstructured":"JohnsonDW HerzigKA GissaneR CampbellSB HawleyCM IsbelNM.A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in PD patients.Nephrol. Dial. Transplant.2001;16:1879\u201384.","DOI":"10.1093\/ndt\/16.9.1879"},{"key":"e_1_2_15_10_2","unstructured":"AggarwalHK NandN SinghS SinghM Hemant KaushikG.Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin.J. Assoc. Physicians India2003;51:170\u201374."},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.06.018"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.suppl_4.43"},{"key":"e_1_2_15_13_2","first-page":"238","article-title":"The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients","volume":"44","author":"Fishbane S","year":"1995","journal-title":"Clin. Nephrol."},{"issue":"2","key":"e_1_2_15_14_2","first-page":"S99","article-title":"Safety of intravenous iron in clinical practice: Implications for anemia management protocols","volume":"15","author":"Aronoff GR","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP60335"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V113530"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2006.00647.x"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.64.s87.10.x"},{"key":"e_1_2_15_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00258-0"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006091034"},{"key":"e_1_2_15_21_2","first-page":"45","article-title":"Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO)","volume":"49","author":"Saltissi D","year":"1998","journal-title":"Clin. Nephrol."},{"key":"e_1_2_15_22_2","first-page":"221","article-title":"Characterisation of iron availability from 3 different iron preparations in dialysis patients","volume":"8","author":"Macdougall IC","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_23_2","first-page":"217.","article-title":"Intravenous iron hydroxy saccharate: Establishing the optimum dose","volume":"8","author":"Chandler G","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90463-1"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70183-6"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92463-6"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000035250.66458.67"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x"},{"key":"e_1_2_15_29_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1681\/ASN.V95869","article-title":"EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients","volume":"9","author":"Hoen B","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000128009.69594.BE"},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005040423"},{"key":"e_1_2_15_32_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1681\/ASN.V133734","article-title":"Iron administration and clinical outcomes in hemodialysis patients","volume":"13","author":"Feldman HI","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00422.x"},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065018"},{"key":"e_1_2_15_35_2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.V124814","article-title":"Is C\u2010reactive protein a useful prognostic marker in PD patients?","volume":"12","author":"Herzig KA","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00273.x"},{"key":"e_1_2_15_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70200-9"},{"key":"e_1_2_15_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90339-5"},{"key":"e_1_2_15_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-200101000-00017"},{"key":"e_1_2_15_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_1.53"},{"key":"e_1_2_15_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70259-3"},{"key":"e_1_2_15_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1797.8.s.8.x"},{"key":"e_1_2_15_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2003.16096.x"},{"key":"e_1_2_15_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_8.33"},{"key":"e_1_2_15_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000137879.97445.6E"},{"key":"e_1_2_15_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66020.x"},{"key":"e_1_2_15_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_7.25"},{"key":"e_1_2_15_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01528.x"},{"key":"e_1_2_15_49_2","doi-asserted-by":"publisher","DOI":"10.1159\/000089266"},{"key":"e_1_2_15_50_2","first-page":"693","article-title":"Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients \u2013 A prospective cross\u2010over study","volume":"17","author":"Hsu PY","year":"2004","journal-title":"J. Nephrol."},{"key":"e_1_2_15_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.8.1207"},{"key":"e_1_2_15_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2005.18304.x"},{"key":"e_1_2_15_53_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.12.025"},{"key":"e_1_2_15_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00920.x"},{"key":"e_1_2_15_55_2","first-page":"422","article-title":"Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy","volume":"49","author":"Sirken G","year":"2003","journal-title":"ASAIO J."},{"key":"e_1_2_15_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000131523.17045.56"},{"key":"e_1_2_15_57_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655999750016113"},{"key":"e_1_2_15_58_2","first-page":"154","article-title":"Removal of high molecular weight substances with large porse size membrane (BK\u2010F)","volume":"34","author":"Kobayashi H","year":"1993","journal-title":"Kidney Dial."},{"key":"e_1_2_15_59_2","first-page":"200","article-title":"Effect on alleviation of renal anemia by haemodialysis using the high\u2010flux dialyzer (BK\u2010F)","volume":"34","author":"Kawano Y","year":"1994","journal-title":"Kidney Dial."},{"issue":"8","key":"e_1_2_15_60_2","first-page":"viii29","article-title":"Dialysis adequacy and response to erythropoietic agents: What is the evidence base?","volume":"18","author":"Locatelli F","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_15_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.9.1399"},{"key":"e_1_2_15_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200304103481514"},{"key":"e_1_2_15_63_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186147"},{"key":"e_1_2_15_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.36"},{"key":"e_1_2_15_65_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2002.06878.x"},{"key":"e_1_2_15_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00356-1"},{"key":"e_1_2_15_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2005.00424.x"},{"key":"e_1_2_15_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000109"},{"key":"e_1_2_15_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70047-3"},{"key":"e_1_2_15_70_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.34925"},{"key":"e_1_2_15_71_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.21286"},{"key":"e_1_2_15_72_2","unstructured":"SantiagoGC RaoTK LairdNM.Effect of dialysis therapy on the hematopoietic system: The National Cooperative Dialysis Study.Kidney Int. Suppl.1983:S95\u2013100."},{"key":"e_1_2_15_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602153340702"},{"key":"e_1_2_15_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.1.111"},{"key":"e_1_2_15_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-200201000-00012"},{"key":"e_1_2_15_76_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112157"},{"key":"e_1_2_15_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2006.00141.x"},{"key":"e_1_2_15_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.10.2708"},{"key":"e_1_2_15_79_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073438"},{"key":"e_1_2_15_80_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-004-1563-0"},{"key":"e_1_2_15_81_2","doi-asserted-by":"publisher","DOI":"10.1159\/000168443"},{"key":"e_1_2_15_82_2","first-page":"190","article-title":"Profile of anemia in chronic renal failure patients: Comparison between predialyzed and dialyzed patients at the Division of Nephrology, Department of Internal Medicine, Sanglah Hospital, Denpasar, Bali, Indonesia","volume":"37","author":"Suega K","year":"2005","journal-title":"Acta Med. Indones."},{"key":"e_1_2_15_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi086"},{"key":"e_1_2_15_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-2021-7"},{"key":"e_1_2_15_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.supp6.44"},{"key":"e_1_2_15_86_2","doi-asserted-by":"publisher","DOI":"10.1159\/000089449"},{"key":"e_1_2_15_87_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186237"},{"key":"e_1_2_15_88_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188942"},{"key":"e_1_2_15_89_2","doi-asserted-by":"publisher","DOI":"10.1159\/000089450"},{"key":"e_1_2_15_90_2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1681\/ASN.V133708","article-title":"Effects of 1\u2010carnitine supplementation in maintenance hemodialysis patients: A systematic review","volume":"13","author":"Hurot JM","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"e_1_2_15_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(01)70008-X"},{"key":"e_1_2_15_92_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118484"},{"key":"e_1_2_15_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.supp6.27"},{"key":"e_1_2_15_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70394-X"},{"key":"e_1_2_15_95_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-6-775"},{"key":"e_1_2_15_96_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.69.808.124"},{"key":"e_1_2_15_97_2","first-page":"49","article-title":"Correction of haemodialysis\u2010associated anaemia by deferoxamine. Effects on serum aluminum and iron overload","volume":"131","author":"Von Bonsdorff M","year":"1990","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"e_1_2_15_98_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186374"},{"key":"e_1_2_15_99_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2003.s.005"},{"key":"e_1_2_15_100_2","first-page":"379","article-title":"Treatment of associated anemia in different hematological disorders with epoetin alpha","volume":"51","author":"Maisnar V","year":"2004","journal-title":"Neoplasma"},{"key":"e_1_2_15_101_2","first-page":"29","article-title":"Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer","volume":"19","author":"Abels RI","year":"1992","journal-title":"Semin. Oncol."},{"key":"e_1_2_15_102_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200160"},{"key":"e_1_2_15_103_2","doi-asserted-by":"publisher","DOI":"10.1159\/000097464"},{"issue":"3","key":"e_1_2_15_104_2","first-page":"95","article-title":"Erythropoietin\u2010induced, antibody\u2010mediated pure red cell aplasia","volume":"35","author":"Rossert J","year":"2005","journal-title":"Eur. J. Clin. Invest."},{"key":"e_1_2_15_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16302-2"},{"key":"e_1_2_15_106_2","unstructured":"WoodburnKW WinslowS LeutherKK.Hematide a Peptidic Erythropoiesis Stimulating Agent that Corrects Anaemia Induced by Partial Nephrectomy and Erythropoietin\u2010specific Antibodies in Rats. European Haematology Association Meeting Stockholm 2005."},{"key":"e_1_2_15_107_2","first-page":"239","article-title":"Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients","volume":"52","author":"Gallucci MT","year":"1999","journal-title":"Clin. Nephrol."},{"key":"e_1_2_15_108_2","first-page":"817","article-title":"Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle\u2010cell anaemia and renal failure","volume":"7","author":"Tomson CR","year":"1992","journal-title":"Nephrol. Dial. Transplant."},{"key":"e_1_2_15_109_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.11.2949"},{"key":"e_1_2_15_110_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073439"},{"key":"e_1_2_15_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(03)01995-3"}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2007.00810.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2007.00810.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T18:43:24Z","timestamp":1697309004000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2007.00810.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,25]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1440-1797.2007.00810.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2007.00810.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,25]]},"assertion":[{"value":"2007-05-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}